日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials

胸部肿瘤研究者发起试验的开发、审查和启动

Gerber, David E; Wynters, Claire R; Prasad, Tanushree; Schnel, Ronny K; Zhang, Song; Stinchcombe, Thomas E; Villaruz, Liza C; Bauml, Joshua M; Iams, Wade T; Patil, Tejas; Liu, Stephen V; Horn, Leora; Hudak, John M; Camidge, D Ross

Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.

Exportin 1 抑制剂 Selinexor 联合多西他赛治疗既往接受过治疗的晚期 KRAS 突变型非小细胞肺癌的 I/II 期试验

von Itzstein Mitchell S, Burns Timothy F, Dowell Jonathan E, Horn Leora, Camidge D Ross, York Sally J, Eaton Keith D, Kyle Kelly, Fattah Farjana, Liu Jialiang, Mu-Mosley Hong, Gupta Arjun, Nadeem Urooba, Gao Ang, Zhang Song, Gerber David E

Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors

阿法替尼和奈西妥单抗治疗获得性酪氨酸激酶抑制剂耐药的EGFR突变型非小细胞肺癌

Myall, Nathaniel J; Whisenant, Jennifer G; Neal, Joel W; Iams, Wade T; Reckamp, Karen L; York, Sally; Berry, Lynne D; Shyr, Yu; Horn, Leora; Wakelee, Heather A; Padda, Sukhmani K

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors

一项评估纳武利尤单抗联合血管内皮生长因子酪氨酸激酶抑制剂沃罗拉尼治疗难治性胸部肿瘤患者的安全性和活性的 1/2 期研究

Beckermann, Kathryn E; Bestvina, Christine M; El Osta, Badi; Sanborn, Rachel E; Borghaei, Hossein; Lammers, Philip Edward; Selvaggi, Giovanni; Whisenant, Jennifer G; Heimann-Nichols, Ellen; Berry, Lynne; Hsu, Chih-Yuan; Shyr, Yu; Horn, Leora; Wakelee, Heather

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer

肺癌患者可避免住院的识别与特征分析

Lander, Eric M; Li, Xuanyi; Huang, Li-Ching; Cass, Amanda S; Iams, Wade T; Skotte, Emily A; Whisenant, Jennifer G; Ramirez, Robert A; York, Sally J; Osterman, Travis J; Lewis, Jennifer A; Lovly, Christine M; Shyr, Yu; Horn, Leora

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

针对确诊合并2019冠状病毒病(COVID-19)的胸部恶性肿瘤患者的明确预后系统:来自TERAVOLT注册研究的最新进展

Whisenant, Jennifer G; Baena, Javier; Cortellini, Alessio; Huang, Li-Ching; Lo Russo, Giuseppe; Porcu, Luca; Wong, Selina K; Bestvina, Christine M; Hellmann, Matthew D; Roca, Elisa; Rizvi, Hira; Monnet, Isabelle; Boudjemaa, Amel; Rogado, Jacobo; Pasello, Giulia; Leighl, Natasha B; Arrieta, Oscar; Aujayeb, Avinash; Batra, Ullas; Azzam, Ahmed Y; Unk, Mojca; Azab, Mohammed A; Zhumagaliyeva, Ardak N; Gomez-Martin, Carlos; Blaquier, Juan B; Geraedts, Erica; Mountzios, Giannis; Serrano-Montero, Gloria; Reinmuth, Niels; Coate, Linda; Marmarelis, Melina; Presley, Carolyn J; Hirsch, Fred R; Garrido, Pilar; Khan, Hina; Baggi, Alice; Mascaux, Celine; Halmos, Balazs; Ceresoli, Giovanni L; Fidler, Mary J; Scotti, Vieri; Métivier, Anne-Cécile; Falchero, Lionel; Felip, Enriqueta; Genova, Carlo; Mazieres, Julien; Tapan, Umit; Brahmer, Julie; Bria, Emilio; Puri, Sonam; Popat, Sanjay; Reckamp, Karen L; Morgillo, Floriana; Nadal, Ernest; Mazzoni, Francesca; Agustoni, Francesco; Bar, Jair; Grosso, Federica; Avrillon, Virginie; Patel, Jyoti D; Gomes, Fabio; Ibrahim, Ehab; Trama, Annalisa; Bettini, Anna C; Barlesi, Fabrice; Dingemans, Anne-Marie; Wakelee, Heather; Peters, Solange; Horn, Leora; Garassino, Marina Chiara; Torri, Valter

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Cox比例风险比高估了免疫检查点抑制剂的生存获益:Cox-TEL校正及程序性死亡配体1表达与免疫检查点抑制剂生存获益的荟萃分析

Lin, Emily Pei-Ying; Hsu, Chih-Yuan; Chiou, Jeng-Fong; Berry, Lynne; Horn, Leora; Bunn, Paul; Yang, James Chih-Hsin; Yang, Pan-Chyr; Adjei, Alex A; Shyr, Yu

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

流感疫苗接种与接受免疫检查点抑制剂治疗的晚期胸部肿瘤患者免疫相关不良事件严重程度的关联

Lin, Emily Pei-Ying; Huang, Li-Ching; Whisenant, Jennifer; York, Sally; Osterman, Travis; Lewis, Jennifer; Iams, Wade; Skotte, Emily; Cass, Amanda; Hsu, Chih-Yuan; Shyr, Yu; Horn, Leora

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

冠状病毒病 2019 的预后、患者疫苗接种状况以及 Omicron 疫苗接种高峰期间癌症相关延误:TERAVOLT 分析简报

Bestvina, Christine M; Whisenant, Jennifer G; Torri, Valter; Cortellini, Alessio; Wakelee, Heather; Peters, Solange; Roca, Elisa; De Toma, Alessandro; Hirsch, Fred R; Mamdani, Hirva; Halmos, Balazs; Arrieta, Oscar; Metivier, Anne-Cecile; Fidler, Mary J; Rogado, Jacobo; Presley, Carolyn J; Mascaux, Celine; Genova, Carlo; Blaquier, Juan Bautista; Addeo, Alfredo; Finocchiaro, Giovanna; Khan, Hina; Mazieres, Julien; Morgillo, Floriana; Bar, Jair; Aujayeb, Avinash; Mountzios, Giannis; Scotti, Vieri; Grosso, Federica; Geraedts, Erica; Zhumagaliyeva, Ardak N; Horn, Leora; Garassino, Marina Chiara; Baena, Javier

COVID-19 in patients with cancer: managing a pandemic within a pandemic

癌症患者中的新冠肺炎:在疫情之中应对疫情

Horn, Leora; Garassino, Marina